| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dacetuzumab | tumor necrosis factor receptor superfamily member 5 | biotech | NA | drugbank , DGIDB | Lymphoma[MeSHID:D008223] Multiple Myeloma[MeSHID:D009101] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cessation of life[MeSHID:D003643] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Expiration function[MeSHID:D045853] |
17.36 | investigational | inhibitor |
| dacetuzumab | tumor necrosis factor receptor superfamily member 5 | biotech | NA | drugbank , DGIDB | Lymphoma[MeSHID:D008223] Multiple Myeloma[MeSHID:D009101] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Cessation of life[MeSHID:D003643] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Expiration function[MeSHID:D045853] |
17.36 | investigational | unknown |
| click here to return to the previous page | ||||||||